Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery |
| |
Authors: | Dai Hui Jiang Xuan Tan Geoffrey C Y Chen Yong Torbenson Michael Leong Kam W Mao Hai-Quan |
| |
Institution: | Tissue and Therapeutic Engineering Lab, Division of Johns Hopkins in Singapore, Singapore. |
| |
Abstract: | The goal of this study was to examine the efficacy of liver-targeted gene delivery by chitosan-DNA nanoparticles through retrograde intrabiliary infusion (RII). The transfection efficiency of chitosan-DNA nanoparticles, as compared with PEI-DNA nanoparticles or naked DNA, was evaluated in Wistar rats by infusion into the common bile duct, portal vein, or tail vein. Chitosan-DNA nanoparticles administrated through the portal vein or tail vein did not produce detectable luciferase expression. In contrast, rats that received chitosan-DNA nanoparticles showed more than 500 times higher luciferase expression in the liver 3 days after RII; and transgene expression levels decreased gradually over 14 days. Luciferase expression in the kidney, lung, spleen, and heart was negligible compared with that in the liver. RII of chitosan-DNA nanoparticles did not yield significant toxicity and damage to the liver and biliary tree as evidenced by liver function analysis and histopathological examination. Luciferase expression by RII of PEI-DNA nanoparticles was 17-fold lower than that of chitosan-DNA nanoparticles on day 3, but it increased slightly over time. These results suggest that RII is a promising routine to achieve liver-targeted gene delivery by non-viral nanoparticles; and both gene carrier characteristics and mode of administration significantly influence gene delivery efficiency. |
| |
Keywords: | nanoparticles gene delivery liver-targeted chitosan retrograde intrabiliary infusion |
本文献已被 PubMed 等数据库收录! |
|